Clinical Trials Browser

Interventional × Vinorelbine × CNS × Clear all

NCT06137651 2024-04-01

Trotabresib in Combination With Vinorelbine and Radiation Therapy for the Treatment of HER2+ Breast Cancer With Central Nervous System or Leptomeningeal Metastasis

Phase 1 Withdrawn

Brain Neoplasms, Breast Neoplasms, Meningeal Carcinomatosis

NCT03620032 2023-12-06

DIPG

Phase 2 Unknown

Diffuse Intrinsic Pontine Glioma

NCT03933982 2019-05-29

Pyrotinib

Phase 2 Unknown

Brain Neoplasms, Breast Neoplasms

NCT01305941 2018-12-17

A Study Of Everolimus, Trastuzumab And Vinorelbine In HER2-Positive Breast Cancer Brain Metastases

Phase 2 Completed

32 enrolled 19 charts

Brain Neoplasms, Breast Neoplasms

NCT01155258 2016-06-13

Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors

Phase 1 Completed

BreastCNSDermatologicEndocrineGenitourinaryGynecologicThoracic

Carcinoma, Ovarian Epithelial, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Paraganglioma, Extra-Adrenal, Pheochromocytoma, Prostatic Neoplasms, Carcinoma, Merkel Cell, Endometrial Neoplasms, Carcinoma, Islet Cell, Carcinoma, Medullary, Breast Neoplasms, Male, Small Cell Lung Carcinoma

NCT00026494 2016-01-18

Temozolomide and Vinorelbine in Treating Patients With Recurrent Brain Metastases

Phase 1/2 Completed

49 enrolled 9 charts

Brain Neoplasms, Neoplasm Metastasis

NCT00003234 2014-07-28

Vinorelbine in Treating Children With Recurrent or Refractory Cancers

Phase 2 Completed

Familial ependymoma, Astrocytoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

NCT00180947 2006-09-08

Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in Relapse

Phase 2 Unknown

Medulloblastoma, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Neoplasms, Connective and Soft Tissue